{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T02:50:46Z","timestamp":1770346246902,"version":"3.49.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,9,1]]},"DOI":"10.1038\/sj.bmt.1703654","type":"journal-article","created":{"date-parts":[[2002,9,9]],"date-time":"2002-09-09T11:00:37Z","timestamp":1031569237000},"page":"327-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease"],"prefix":"10.1038","volume":"30","author":[{"given":"P","family":"Szabolcs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Reese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KB","family":"Yancey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RP","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kurtzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,9,3]]},"reference":[{"key":"BF1703654_CR1","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1172\/JCI116033","volume":"90","author":"N Domloge-Hultsch","year":"1992","unstructured":"Domloge-Hultsch N, Gammon WR, Briggaman RA et al. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease J Clin Invest 1992 90: 1628 1633","journal-title":"J Clin Invest"},{"key":"BF1703654_CR2","first-page":"66","volume":"26 (Suppl.\u200914)","author":"AJ Grillo-Lopez","year":"1999","unstructured":"Grillo-Lopez AJ, White CA, Varns C et al. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma Semin Oncol 1999 26 (Suppl.\u200914): 66 73","journal-title":"Semin Oncol"},{"key":"BF1703654_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7326\/0003-4819-133-4-200008150-00011","volume":"133","author":"V Ratanatharathorn","year":"2000","unstructured":"Ratanatharathorn V, Carson E, Reynolds C et al. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease Ann Intern Med 2000 133: 275 279","journal-title":"Ann Intern Med"},{"key":"BF1703654_CR4","first-page":"99","volume":"27 (Suppl.\u200912)","author":"MN Saleh","year":"2000","unstructured":"Saleh MN, Gutheil J, Moore M et al. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia Semin Oncol 2000 27 (Suppl.\u200912): 99 103","journal-title":"Semin Oncol"},{"key":"BF1703654_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1182\/blood.V98.4.952","volume":"98","author":"R Stasi","year":"2001","unstructured":"Stasi R, Pagano A, Stipa E, Amadori S . Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura Blood 2001 98: 952 957","journal-title":"Blood"},{"key":"BF1703654_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1046\/j.1365-2141.2001.02873-4.x","volume":"114","author":"N Ahrens","year":"2001","unstructured":"Ahrens N, Kingreen D, Seltsam A, Salama A . Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab) Br J Haematol 2001 114: 244 245","journal-title":"Br J Haematol"},{"key":"BF1703654_CR7","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1182\/blood.V97.12.3995","volume":"97","author":"M Zecca","year":"2001","unstructured":"Zecca M, De Stefano P, Nobili B, Locatelli F . Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia Blood 2001 97: 3995 3997","journal-title":"Blood"},{"key":"BF1703654_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0952-7915(98)80215-X","volume":"10","author":"TA Waldmann","year":"1998","unstructured":"Waldmann TA, O'Shea J . The use of antibodies against the IL-2 receptor in transplantation Curr Opin Immunol 1998 10: 507 512","journal-title":"Curr Opin Immunol"},{"key":"BF1703654_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V95.1.83","volume":"95","author":"D Przepiorka","year":"2000","unstructured":"Przepiorka D, Kernan NA, Ippoliti C et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease Blood 2000 95: 83 89","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703654","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:25:21Z","timestamp":1648077921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,1]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9,1]]}},"alternative-id":["BF1703654"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703654","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,1]]},"assertion":[{"value":"26 April 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}